Free tool
Stocks near their 52-week high
We cover 159 companies trading within 5% of their own 52-week high. The median market value in the group is $5.07B. Across the group, the median move over the past trading day is +0.13%. 99% of the 158 with a 200-day average trade above it. Price change over the past year runs from +15.8% to +200.3% across the middle 80 percent of the group, with a median of +56.7%. Across the group, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
159 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% | Oct 29, 2026 |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% | Oct 13, 2026 |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% | Oct 29, 2026 |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% | Oct 29, 2026 |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% | Oct 29, 2026 |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% | Nov 3, 2026 |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% | Oct 21, 2026 |
| GIS.DE | Gilead Sciences, Inc. | 126.78 EUR | +7.51% | +23.41% | +33.64% | Oct 29, 2026 |
| PFE | Pfizer Inc. | $28.30 | +12.08% | +16.16% | +18.72% | Nov 3, 2026 |
| PFE.DE | Pfizer Inc. | 24.44 EUR | +10.09% | +18.44% | +22.96% | Nov 3, 2026 |
| VX1.DE | Vertex Pharmaceuticals Incorporated | 475.00 EUR | +10.21% | +23.55% | +41.64% | Nov 2, 2026 |
| VRTX | Vertex Pharmaceuticals Incorporated | $547.29 | +11.60% | +21.05% | +40.66% | Nov 2, 2026 |
| BMY | Bristol-Myers Squibb Company | $67.57 | +6.24% | +27.70% | +47.01% | Oct 29, 2026 |
| REGN | Regeneron Pharmaceuticals, Inc. | $814.79 | +17.21% | +5.24% | +39.36% | Oct 28, 2026 |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% | Oct 22, 2026 |
| 0QF.DE | Moderna, Inc. | 136.12 EUR | +181.04% | +417.17% | +550.51% | Nov 5, 2026 |
| TAK | Takeda Pharmaceutical Company Limited | $18.23 | +4.05% | +16.71% | +22.68% | Oct 29, 2026 |
| 4502.T | Takeda Pharmaceutical Company Limited | 5,791.00 JPY | −0.96% | +19.85% | +36.03% | Oct 29, 2026 |
| BDX | Becton, Dickinson and Company | $190.21 | +14.35% | +24.91% | +25.97% | Nov 5, 2026 |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% | Nov 5, 2026 |
| RVMD | Revolution Medicines, Inc. | $215.44 | +17.18% | +172.64% | +466.35% | Nov 4, 2026 |
| TEVA | Teva Pharmaceutical Industries Limited | $37.92 | +19.73% | +22.52% | +110.08% | Nov 4, 2026 |
| IQV | IQVIA Holdings Inc. | $261.51 | +7.64% | +16.04% | +38.51% | Nov 3, 2026 |
| ONC | BeOne Medicines AG | $375.80 | +13.72% | +20.83% | +25.21% | Nov 5, 2026 |
| WAT | Waters Corporation | $414.17 | +7.88% | +8.43% | +40.57% | Oct 30, 2026 |
| 4578.T | Otsuka Holdings Co., Ltd. | 12,260.00 JPY | +6.56% | +35.48% | +57.62% | Oct 29, 2026 |
| RPRX | Royalty Pharma plc | $61.80 | +3.05% | +60.57% | +74.00% | Nov 4, 2026 |
| ILU.DE | Illumina, Inc. | 193.08 EUR | +13.91% | +69.73% | +129.80% | Oct 29, 2026 |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% | Oct 29, 2026 |
| DXCM | DexCom, Inc. | $88.96 | +18.85% | +33.69% | +16.47% | Oct 29, 2026 |
| DC4.DE | DexCom, Inc. | 77.60 EUR | +16.52% | +37.44% | +21.06% | Oct 29, 2026 |
| BIIB | Biogen Inc. | $221.07 | +7.52% | +24.32% | +62.12% | Oct 29, 2026 |
| IDP.DE | Biogen Inc. | 190.12 EUR | +0.21% | +26.49% | +65.32% | Oct 29, 2026 |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% | Nov 3, 2026 |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% | Oct 20, 2026 |
| ROIV | Roivant Sciences Ltd. | $36.75 | +8.60% | +67.58% | +206.51% | Nov 9, 2026 |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% | Oct 27, 2026 |
| GH | Guardant Health, Inc. | $170.92 | +19.01% | +68.00% | +169.17% | Oct 28, 2026 |
| THC | Tenet Healthcare Corporation | $274.19 | +4.40% | +37.47% | +50.70% | Oct 27, 2026 |
| GMAB | Genmab A/S | $33.75 | +16.38% | +6.07% | +36.20% | Nov 5, 2026 |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% | Nov 5, 2026 |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% | Oct 27, 2026 |
| SOLV | Solventum Corporation | $91.53 | +6.22% | +15.83% | +25.57% | Nov 5, 2026 |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | 36.47 AUD | +5.19% | +12.67% | +11.27% | Nov 24, 2026 |
| 7733.T | Olympus Corporation | 2,162.50 JPY | +16.11% | +8.42% | +27.06% | Nov 10, 2026 |
| CRL | Charles River Laboratories International, Inc. | $295.10 | +22.74% | +45.79% | +81.27% | Nov 4, 2026 |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% | Oct 27, 2026 |
| RVTY | Revvity, Inc. | $126.35 | +13.31% | +28.91% | +42.93% | Oct 26, 2026 |
| ORNBV.HE | Orion Oyj | 80.80 EUR | −1.76% | +29.38% | +21.01% | Oct 28, 2026 |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.53% | +10.68% | +1.80% | Nov 10, 2026 |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% | Nov 2, 2026 |
| TECH | Bio-Techne Corporation | $72.38 | +0.43% | +21.73% | +29.33% | Nov 9, 2026 |
| PRAX | Praxis Precision Medicines, Inc. | $377.37 | +27.57% | +31.76% | +704.28% | Nov 9, 2026 |
| KYMR | Kymera Therapeutics, Inc. | $125.55 | +18.26% | +72.55% | +197.09% | Nov 3, 2026 |
| BIO | Bio-Rad Laboratories, Inc. | $388.64 | +17.41% | +27.31% | +32.71% | Oct 29, 2026 |
| HSIC | Henry Schein, Inc. | $90.38 | +5.45% | +17.65% | +31.02% | Nov 3, 2026 |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% | Nov 3, 2026 |
| APGE | Apogee Therapeutics, Inc. | $134.95 | +0.58% | +78.08% | +257.11% | Nov 9, 2026 |
| TWST | Twist Bioscience Corporation | $150.06 | +69.46% | +363.29% | +451.89% | Nov 16, 2026 |
| IMVT | Immunovant, Inc. | $43.89 | +12.83% | +69.39% | +189.13% | Nov 9, 2026 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% | Nov 5, 2026 |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% | Nov 5, 2026 |
| SRRK | Scholar Rock Holding Corporation | $60.04 | +21.61% | +40.28% | +74.18% | Nov 12, 2026 |
| 6869.T | Sysmex Corporation | 1,915.50 JPY | +14.53% | +26.54% | +3.66% | Nov 4, 2026 |
| HNGE | Hinge Health, Inc. | $90.50 | +20.27% | +98.64% | +56.66% | Nov 3, 2026 |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% | Oct 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% | Oct 21, 2026 |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% | Nov 9, 2026 |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% | Nov 11, 2026 |
| TVTX | Travere Therapeutics, Inc. | $67.12 | +20.05% | +69.84% | +284.86% | Oct 29, 2026 |
| TFX | Teleflex Incorporated | $138.74 | +3.38% | +13.97% | +8.06% | Oct 29, 2026 |
| SHC | Sotera Health Company | $19.54 | +10.02% | +10.46% | +18.42% | Nov 3, 2026 |
| MMSI | Merit Medical Systems, Inc. | $90.54 | +15.65% | +4.73% | −0.28% | Oct 29, 2026 |
| ACAD | ACADIA Pharmaceuticals Inc. | $29.58 | +13.73% | +12.51% | +11.33% | Nov 4, 2026 |
| DYN | Dyne Therapeutics, Inc. | $26.36 | +1.78% | +42.49% | +93.26% | Nov 5, 2026 |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% | Nov 5, 2026 |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% | Nov 11, 2026 |
| CON | Concentra Group Holdings Parent, Inc. | $34.95 | +6.91% | +81.01% | +50.93% | Nov 5, 2026 |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% | Nov 11, 2026 |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% | Oct 29, 2026 |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% | Nov 4, 2026 |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% | Nov 9, 2026 |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% | Nov 5, 2026 |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% | Oct 27, 2026 |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% | Oct 23, 2026 |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% | Nov 9, 2026 |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% | Nov 5, 2026 |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% | Nov 5, 2026 |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% | Nov 12, 2026 |
| AXGN | AxoGen, Inc. Common Stock | $51.58 | +25.35% | +66.39% | +219.58% | Oct 28, 2026 |
| PGEN | Precigen, Inc. | $7.42 | +34.18% | +73.36% | +61.66% | Nov 12, 2026 |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% | Nov 3, 2026 |
| PHVS | Pharvaris N.V. | $37.00 | +9.97% | +39.73% | +55.59% | Nov 12, 2026 |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% | Nov 13, 2026 |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% | Nov 5, 2026 |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% | Oct 29, 2026 |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% | Oct 27, 2026 |
| HRMY | Harmony Biosciences Holdings, Inc. | $39.66 | +10.88% | +6.10% | +4.23% | Nov 3, 2026 |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% | Oct 27, 2026 |
| ADUS | Addus HomeCare Corporation | $120.71 | +1.25% | +13.26% | +4.50% | Nov 2, 2026 |
| PVLA | Palvella Therapeutics, Inc. | $154.33 | +8.04% | +53.90% | +173.39% | Nov 11, 2026 |
| MD | Pediatrix Medical Group, Inc. | $26.95 | +0.34% | +26.59% | +56.87% | Nov 2, 2026 |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% | Nov 5, 2026 |
| 6960.T | Fukuda Denshi Co., Ltd. | 11,970.00 JPY | +5.37% | +57.28% | +79.12% | Oct 29, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% | Oct 22, 2026 |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% | Nov 4, 2026 |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% | Nov 5, 2026 |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% | Nov 6, 2026 |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% | Nov 9, 2026 |
| LBRX | LB Pharmaceuticals Inc | $48.17 | +37.85% | +135.64% | +178.41% | Nov 12, 2026 |
| REPL | Replimune Group, Inc. | $15.88 | +196.82% | +78.43% | +187.16% | Nov 5, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% | Nov 5, 2026 |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% | Nov 4, 2026 |
| ANRO | Alto Neuroscience, Inc. | $36.53 | +33.22% | +120.19% | +786.65% | Nov 11, 2026 |
| MGTX | MeiraGTx Holdings plc | $14.92 | +26.23% | +91.04% | +100.54% | Nov 12, 2026 |
| DRTS | Alpha Tau Medical Ltd. | $14.96 | +29.52% | +209.73% | +343.92% | Nov 19, 2026 |
| NUTX | Nutex Health Inc. | $195.92 | +31.46% | +32.21% | +118.22% | Nov 5, 2026 |
| CRON.TO | Cronos Group Inc. | 4.95 CAD | +23.75% | +34.15% | +39.83% | Nov 5, 2026 |
| CRON | Cronos Group Inc. | $3.55 | +24.56% | +31.48% | +38.67% | Nov 5, 2026 |
| 6523.T | PHC Holdings Corporation | 1,527.00 JPY | +36.71% | +37.93% | +58.42% | Nov 11, 2026 |
| ABUS | Arbutus Biopharma Corporation | $5.19 | +17.69% | +8.81% | +42.19% | Nov 16, 2026 |
| CADL | Candel Therapeutics, Inc. | $13.28 | +37.19% | +144.12% | +124.70% | Nov 12, 2026 |
| TALK | Talkspace, Inc. | $5.25 | +0.77% | +49.57% | +93.73% | Oct 29, 2026 |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% | Nov 5, 2026 |
| UU8.F | Neurogene Inc. | 33.20 EUR | +21.17% | +29.18% | +165.60% | Nov 12, 2026 |
| VREX | Varex Imaging Corporation | $18.48 | +66.04% | +58.63% | +61.40% | Nov 17, 2026 |
| SOPH | SOPHiA GENETICS SA | $8.53 | +53.14% | +82.66% | +156.16% | Nov 3, 2026 |
| OABI | OmniAb, Inc. | $4.81 | +144.16% | +155.85% | +198.76% | Nov 4, 2026 |
| 7575.T | Japan Lifeline Co., Ltd. | 1,565.00 JPY | +7.93% | +0.59% | +12.02% | Oct 29, 2026 |
| GUD.TO | Knight Therapeutics Inc. | 9.76 CAD | −0.81% | +65.14% | +50.39% | Nov 5, 2026 |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% | Nov 12, 2026 |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% | Oct 1, 2026 |
| CTNM | Contineum Therapeutics, Inc. | $17.02 | +20.20% | +49.43% | +70.03% | Oct 29, 2026 |
| EOLS | Evolus, Inc. | $8.78 | +41.16% | +30.65% | +15.83% | Nov 4, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% | Nov 11, 2026 |
| PBYI | Puma Biotechnology, Inc. | $9.16 | +14.93% | +58.75% | +79.61% | Nov 5, 2026 |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% | Nov 5, 2026 |
| FRX.TO | Fennec Pharmaceuticals Inc. | 17.00 CAD | +21.86% | +63.30% | +36.00% | Nov 12, 2026 |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% | Nov 6, 2026 |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% | Oct 22, 2026 |
| IKT | Inhibikase Therapeutics, Inc. | $2.49 | +7.79% | +27.69% | +39.11% | Nov 13, 2026 |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% | Nov 5, 2026 |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% | Nov 11, 2026 |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% | Nov 3, 2026 |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% | Aug 28, 2026 |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% | Sep 29, 2026 |
| ORMP | Oramed Pharmaceuticals Inc. | $5.34 | +28.06% | +96.84% | +159.19% | Nov 12, 2026 |
| LOVE.TO | Cannara Biotech Inc. | 1.99 CAD | +5.29% | +11.80% | +11.80% | Nov 23, 2026 |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.97 | +69.86% | +125.38% | +163.82% | Nov 3, 2026 |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% | Oct 29, 2026 |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% | Nov 11, 2026 |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% | Oct 23, 2026 |
| NOVN.SW | Novartis AG | 128.34 CHF | −1.08% | +21.88% | +30.24% | Oct 27, 2026 |
| SOON.SW | Sonova Holding AG | 245.00 CHF | +10.16% | +17.62% | +6.01% | Nov 12, 2026 |
| YPSN.SW | Ypsomed Holding AG | 407.20 CHF | +4.36% | +24.15% | +4.01% | Nov 11, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.